You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020179019
Dec 20202807
Jan 20214307
Feb 20213204
Mar 202148012
Apr 202136011
May 20217014
Jun 2021005
Jul 2021009
Aug 20210010
Sep 20210018
Oct 202158031
Nov 202154019
Dec 202129016
Jan 20223604
Feb 20222605
Mar 20225607
Apr 202278018
May 202252011
Jun 202256013
Jul 20224606
Aug 202295011
Sep 2022104010
Oct 20227308
Nov 20226808
Dec 20223604
Jan 20237606
Feb 20234403
Mar 20234204
Apr 20236605
May 20234406
Jun 20235203
Jul 20234207
Aug 20233802
Sep 20233203
Oct 20233804
Nov 20234805
Dec 20236803
Jan 20243003
Feb 20249808
Mar 20245802
Apr 20245004
May 2024108010
Jun 20244203
Jul 20242405
Aug 20242002
Sep 20241602
Oct 202416010
Nov 20243804
Dec 20244605
Jan 202530012
Feb 20258010
Mar 2025003
Apr 2025002
May 2025002
Jun 20251016
Total24150441